129 related articles for article (PubMed ID: 19152185)
1. Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours.
Karim RZ; Scolyer RA; Tse GM; Tan PH; Putti TC; Lee CS
Pathology; 2009 Feb; 41(2):105-17. PubMed ID: 19152185
[TBL] [Abstract][Full Text] [Related]
2. Expression of biomarkers in the AKT pathway correlates with malignancy and recurrence in phyllodes tumours of the breast.
Li J; Ho WY; Tsang JYS; Ni YB; Chan SK; Tse GM
Histopathology; 2019 Mar; 74(4):567-577. PubMed ID: 30383904
[TBL] [Abstract][Full Text] [Related]
3. Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours.
Karim RZ; Gerega SK; Yang YH; Horvath L; Spillane A; Carmalt H; Scolyer RA; Lee CS
J Clin Pathol; 2009 Nov; 62(11):1016-20. PubMed ID: 19861560
[TBL] [Abstract][Full Text] [Related]
4. Recent insights into the molecular pathogenesis of mammary phyllodes tumours.
Karim RZ; O'Toole SA; Scolyer RA; Cooper CL; Chan B; Selinger C; Yu B; Carmalt H; Mak C; Tse GM; Tan PH; Putti TC; Lee CS
J Clin Pathol; 2013 Jun; 66(6):496-505. PubMed ID: 23404800
[TBL] [Abstract][Full Text] [Related]
5. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
Sawyer EJ; Hanby AM; Rowan AJ; Gillett CE; Thomas RE; Poulsom R; Lakhani SR; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2002 Apr; 196(4):437-44. PubMed ID: 11920740
[TBL] [Abstract][Full Text] [Related]
6. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
Meyer B; Stirzaker C; Ramkomuth S; Harvey K; Chan B; Lee CS; Karim R; Deng N; Avery-Kiejda KA; Scott RJ; Lakhani S; Fox S; Robbins E; Shin JS; Beith J; Gill A; Sioson L; Chan C; Krishnaswamy M; Cooper C; Warrier S; Mak C; Rasko JE; Bailey CG; Swarbrick A; Clark SJ; O'Toole S; Pidsley R
J Pathol; 2024 Apr; 262(4):480-494. PubMed ID: 38300122
[TBL] [Abstract][Full Text] [Related]
7. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.
Lien HC; Wang CC; Huang CS; Yang YW; Kuo WH; Yao YT
Virchows Arch; 2013 Feb; 462(2):155-61. PubMed ID: 23291960
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.
Jones AM; Mitter R; Springall R; Graham T; Winter E; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
J Pathol; 2008 Apr; 214(5):533-44. PubMed ID: 18288784
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay.
Kuijper A; Buerger H; Simon R; Schaefer KL; Croonen A; Boecker W; van der Wall E; van Diest PJ
J Pathol; 2002 Aug; 197(5):575-81. PubMed ID: 12210075
[TBL] [Abstract][Full Text] [Related]
12. Integrating single-cell and spatial transcriptomes reveals COL4A1/2 facilitates the spatial organisation of stromal cells differentiation in breast phyllodes tumours.
Li X; Yu X; Bi J; Jiang X; Zhang L; Li Z; Shao M
Clin Transl Med; 2024 Mar; 14(3):e1611. PubMed ID: 38481388
[TBL] [Abstract][Full Text] [Related]
13. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
15. Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.
Tsang JYS; Hui YK; Lee MA; Lacambra M; Ni YB; Cheung SY; Wu C; Kwong A; Tse GMK
Sci Rep; 2018 Mar; 8(1):3881. PubMed ID: 29497099
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis.
Lien HC; Huang CS; Yang YW; Jeng YM
Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290
[TBL] [Abstract][Full Text] [Related]
17. p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours.
Karim RZ; Gerega SK; Yang YH; Spillane A; Carmalt H; Scolyer RA; Lee CS
Histopathology; 2010 Jun; 56(7):868-75. PubMed ID: 20497245
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.
Sawyer EJ; Hanby AM; Ellis P; Lakhani SR; Ellis IO; Boyle S; Tomlinson IP
Am J Pathol; 2000 Mar; 156(3):1093-8. PubMed ID: 10702425
[TBL] [Abstract][Full Text] [Related]
19. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
[TBL] [Abstract][Full Text] [Related]
20. C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast.
Liu J; Liu X; Feng X; Liu J; Lv S; Zhang W; Niu Y
Breast Cancer Res Treat; 2015 Jan; 149(2):395-401. PubMed ID: 25534827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
